A61K 38/2033
Il-5
Official title: {il-5}
A61K38/2033 (Il-5) appears on 27 US grants and 45 published applications in this corpus.
Search patents in A61K- Granted patents
- 27
- Published applications
- 45
- Assignees
- 30
- Inventors
- 82
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 3 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 2 |
| 2010 | 4 | 3 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 3 |
| 2018 | 2 | 1 |
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 3 |
| 2022 | 6 | 6 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 4 | 3 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for the treatment of epidermolysis bullosa24 Feb 2026US 12,558,316 B2University of Miami
- Methods and compositions for treating inflammatory and autoimmune conditions with ECM-affinity peptides linked to anti-inflammatory agents11 Nov 2025US 12,465,640 B2The University of Chicago
- Methods for improving cognitive function14 Oct 2025US 12,440,513 B2Albany Medical College
- Methods and compositions for producing an adenovirus vector for use with multiple vaccinations29 Jul 2025US 12,370,250 B2Etubics Corporation
- Eosinophils alleviate lung allograft rejection through their modulation of CD8+ t cells18 Feb 2025US 12,226,453 B2University of Virginia Patent Foundation
- Methods and compositions for the treatment of epidermolysis bullosa2 Jul 2026US 2026/0183238 A1University of Miami
- Methods for improving cognitive function2 Apr 2026US 2026/0091063 A1Albany Medical College
- Methods and compositions for treating inflammatory and autoimmune conditions with ecm-affinity peptides linked to anti-inflammatory agents25 Dec 2025US 2025/0387480 A1The University of Chicago
- Engineered bacterial therapeutics for the treatment of gastrointestinal disease6 Nov 2025US 2025/0339476 A1Northwestern University
- Composition for reducing size or volume of target tissue or kit including same4 Sep 2025US 2025/0276028 A1SK Bioscience Co., Ltd.
Most cited
By later US patents
- Megakaryocyte production27US 5,762,920 AAmgen Inc. · 1998
- Sequential administration of a replication defective adenovirus vector in vaccination protocols15US 8,298,549 B2Etubics Corporation · 2012
- Method for inhibiting production of IGE and method for enhancing production of IGG using interleukin 9 and inhibitors thereof14US 5,132,109 ADepartemente d'Immunologie Institut Henri Beaufour · 1992
- Human amniotic fluid preparation having long-term stability6US 9,579,350 B1MAM Holdings of West Florida, L.L.C. · 2017
- Human amniotic fluid preparation having long-term stability6US 9,884,078 B2MAM Holdings of West Florida, L.L.C. · 2018